These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18044770)

  • 21. Levodopa elevates homocysteine: is this a problem?
    O'Suilleabhain P; Diaz-Arrastia R
    Arch Neurol; 2004 May; 61(5):633-4. PubMed ID: 15148136
    [No Abstract]   [Full Text] [Related]  

  • 22. Levodopa unresponsive symptoms in Parkinson disease.
    Sethi K
    Mov Disord; 2008; 23 Suppl 3():S521-33. PubMed ID: 18781679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosis in Parkinson's disease: how should we treat it?
    Shotbolt P; Samuel M; Anthony D
    Expert Rev Neurother; 2006 Sep; 6(9):1243-6. PubMed ID: 17009911
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimizing long-term therapy for Parkinson disease: levodopa, dopamine agonists, and treatment-associated dyskinesia.
    Stacy M; Galbreath A
    Clin Neuropharmacol; 2008; 31(1):51-6. PubMed ID: 18303491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levodopa-related motor complications--phenomenology.
    Fox SH; Lang AE
    Mov Disord; 2008; 23 Suppl 3():S509-14. PubMed ID: 18781677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of levodopa.
    Nutt JG
    Mov Disord; 2008; 23 Suppl 3():S580-4. PubMed ID: 18781675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia.
    Virmani T; Thenganatt MA; Goldman JS; Kubisch C; Greene PE; Alcalay RN
    Parkinsonism Relat Disord; 2014 Feb; 20(2):245-7. PubMed ID: 24182522
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion.
    Isacson D; Bingefors K; Kristiansen IS; Nyholm D
    Acta Neurol Scand; 2008 Dec; 118(6):379-86. PubMed ID: 18547273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of levodopa-induced motor complications.
    Stocchi F; Tagliati M; Olanow CW
    Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion Parkinson's disease with levodopa abuse and psychosis.
    Tibrewal P; Chuck W; Bastiampillai T; Okungu A; Dhillon R
    Asian J Psychiatr; 2017 Dec; 30():142-143. PubMed ID: 28938150
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel pattern of levodopa-related motor fluctuations: 'paradoxical'on.
    Kim HJ; Kim JY; Ha Paek S; Jeon BS
    Parkinsonism Relat Disord; 2008; 14(4):281-5. PubMed ID: 17980642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levodopa in the early treatment of Parkinson's disease.
    Murata M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When and how should treatment be started in Parkinson disease?
    Lang AE
    Neurology; 2009 Feb; 72(7 Suppl):S39-43. PubMed ID: 19221313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Freezing of Gait and Its Levodopa Paradox.
    Nonnekes J; Bereau M; Bloem BR
    JAMA Neurol; 2020 Mar; 77(3):287-288. PubMed ID: 31841600
    [No Abstract]   [Full Text] [Related]  

  • 36. Association of aspirin with eosinophilia in peripheral blood.
    Cheng TI; Cheng TJ; Chiang SC
    Ann Pharmacother; 2004 Dec; 38(12):2172-3. PubMed ID: 15536142
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluctuating penile erection related with levodopa therapy.
    Jiménez-Jiménez FJ; Tallón-Barranco A; Cabrera-Valdivia F; Gasalla T; Ortí-Pareja M; Zurdo M
    Neurology; 1999 Jan; 52(1):210. PubMed ID: 9921882
    [No Abstract]   [Full Text] [Related]  

  • 38. Parkinson disease: the controversy of levodopa toxicity in Parkinson disease.
    Zesiewicz TA
    Nat Rev Neurol; 2011 Dec; 8(1):8-10. PubMed ID: 22198404
    [No Abstract]   [Full Text] [Related]  

  • 39. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
    Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weighing the neurological complexities of long-term levodopa use.
    Sacks O
    Arch Neurol; 2000 Oct; 57(10):1531. PubMed ID: 11030811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.